Epigenetic reprogramming of mesenchymal stem cells

Advances in Experimental Medicine and Biology

Volumn 754, Issue , 2013, Pages 195-211

  Leu, Yu Wei ^a   Huang, Tim H M ^b   Hsiao, Shu Huei ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^b University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN STRUCTURE; DNA METHYLATION; EPIGENETICS; HIC1 GENE; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RASSF1A GENE; TRIP10 GENE; TUMOR SUPPRESSOR GENE;

EID: 84869057701     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9967-2_10     Document Type: Article

References (144)

1. Agger K, Cloos PA et al (2007) UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449:731-734 (Pubitemid 47552088)
2. Alexanian AR (2007) Epigenetic modi fi ers promote ef fi cient generation of neural-like cells from bone marrow-derived mesenchymal cells grown in neural environment. J Cell Biochem 100:362-371 (Pubitemid 46146086)
3. Arnsdorf EJ, Tummala P et al (2010) The epigenetic mechanism of mechanically induced osteogenic differentiation. J Biomech 43:2881-2886
4. Asahara T, Masuda H et al (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228 (Pubitemid 29377293)
5. Balch C, Nephew KP et al (2007) Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis. Bioessays 29:842-845 (Pubitemid 47424894)
6. Barrand S, Andersen IS et al (2010) Promoter-exon relationship of H3 lysine 9, 27, 36 and 79 methylation on pluripotency-associated genes. Biochem Biophys Res Commun 401:611-617
7. Baylin SB (2005) DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2:S4-S11 (Pubitemid 43135229)
8. Bender CM, Pao MM et al (1998) Inhibition of DNA methylation by 5-aza-2′ -deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 58:95-101 (Pubitemid 28027723)
9. Bianco P, Gehron Robey P (2000) Marrow stromal stem cells. J Clin Invest 105:1663-1668 (Pubitemid 30421745)
10. Bird AP (1980) DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res 8:1499-1504
11. Bird A (1999) DNA methylation de novo. Science 286:2287-2288 (Pubitemid 30016879)
12. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16:6-21 (Pubitemid 34049633)
13. Bird A, Macleod D (2004) Reading the DNA methylation signal. Cold Spring Harb Symp Quant Biol 69:113-118 (Pubitemid 41056544)
14. Bloushtain-Qimron N, Yao J et al (2009) Epigenetic patterns of embryonic and adult stem cells. Cell Cycle 8:809-817
15. Boland GM, Perkins G et al (2004) Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93:1210-1230 (Pubitemid 44264134)
16. Boquest AC, Noer A et al (2006) Epigenetic programming of mesenchymal stem cells from human adipose tissue. Stem Cell Rev 2:319-329 (Pubitemid 47504962)
17. Bork S, Pfister S et al (2010) DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9:54-63
18. Brazelton TR, Rossi FM et al (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290:1775-1779 (Pubitemid 32004810)
19. Buhring HJ, Battula VL et al (2007) Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 1106:262-271 (Pubitemid 47443036)
20. Burdach S, Plehm S et al (2009) Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2. Cell Cycle 8(13):1991-1996
21. Burgold T, Sprea fi co F et al (2008) The histone H3 lysine 27-speci fi c demethylase Jmjd3 is required for neural commitment. PLoS One 3(8):e3034
22. Cameron EE, Bachman KE et al (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21:103-107 (Pubitemid 29036293)
23. Cao Q, Yu J et al (2008) Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27:7274-7284
24. Carvin CD, Kladde MP (2004) Effectors of lysine 4 methylation of histone H3 in Saccharomyces cerevisiae are negative regulators of PHO5 and GAL1-10. J Biol Chem 279:33057-33062 (Pubitemid 39062948)
25. Caudill MA, Wang JC et al (2001) Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J Nutr 131:2811-2818 (Pubitemid 33063107)
26. Chang L, Adams RD et al (2002) The TC10-interacting protein CIP4/2 is required for insulin- stimulated Glut4 translocation in 3T3L1 adipocytes. Proc Natl Acad Sci USA 99:12835-12840
27. Cheng X, Blumenthal RM (2008) Mammalian DNA methyltransferases: a structural perspective. Structure 16:341-350 (Pubitemid 351324115)
28. Christophersen NS, Helin K (2010) Epigenetic control of embryonic stem cell fate. J Exp Med 207:2287-2295
29. Chuang JC, Warner SL et al (2010) S110, a 5-Aza-2′ -deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth. Mol Cancer Ther 9:1443-1450
30. Cironi L, Provero P et al (2009) Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1. PLoS One 4:e7904
31. Cohen NM, Dighe V et al (2009) DNA methylation programming and reprogramming in primate embryonic stem cells. Genome Res 19:2193-2201
32. Collas P (2009) Epigenetic states in stem cells. Biochim Biophys Acta 1790:900-905
33. Cross SH, Bird AP (1995) CpG islands and genes. Curr Opin Genet Dev 5:309-314
34. da Silva ML, Chagastelles PC et al (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213 (Pubitemid 43960310)
35. de Boer J, Siddappa R et al (2004) Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34:818-826 (Pubitemid 38581127)
36. De Boer J, Wang HJ et al (2004) Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 10:393-401 (Pubitemid 38580260)
37. De Miguel MP, Fuentes-Julian S et al (2010) Pluripotent stem cells: origin, maintenance and induction. Stem Cell Rev 6:633-649
38. Dolinoy DC, Weidman JR et al (2006) Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114:567-572
39. Dwyer RM, Kerin MJ (2010) Mesenchymal stem cells and cancer: tumor-speci fi c delivery vehicles or therapeutic targets? Hum Gene Ther 21:1506-1512
40. El-Osta A (2003) DNMT cooperativity - the developing links between methylation, chromatin structure and cancer. Bioessays 25:1071-1084 (Pubitemid 37411767)
41. Ferrari G, Cusella-De Angelis G et al (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530 (Pubitemid 28217075)
42. Fingerman IM, Wu CL et al (2005) Global loss of Set1-mediated H3 Lys4 trimethylation is associated with silencing defects in Saccharomyces cerevisiae. J Biol Chem 280:28761-28765 (Pubitemid 41105777)
43. Gan Q, Yoshida T et al (2007) Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells 25:2-9 (Pubitemid 46052969)
44. Gangaraju VK, Lin H (2009) MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 10:116-125
45. Glinsky GV (2008) "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management. J Clin Oncol 26:2846-2853
46. Gussoni E, Soneoka Y et al (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390-394 (Pubitemid 29454964)
47. Hanna JH, Saha K et al (2010) Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143:508-525
48. Hansen KH, Bracken AP et al (2008) A model for transmission of the H3K27me3 epigenetic mark. Nat Cell Biol 10:1291-1300
49. Hematti P (2011) Human embryonic stem cell-derived mesenchymal progenitors: an overview. Methods Mol Biol 690:163-174
50. Hemberger M, Dean W et al (2009) Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal. Nat Rev Mol Cell Biol 10:526-537
51. Hirata T, Cui YJ et al (2007) The temporal pro fi le of genomic responses and protein synthesis in ischemic tolerance of the rat brain induced by repeated hyperbaric oxygen. Brain Res 1130:214-222 (Pubitemid 46053888)
52. Holbert S, Dedeoglu A et al (2003) Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease. Proc Natl Acad Sci USA 100:2712-2717 (Pubitemid 36297564)
53. Hong S, Cho YW et al (2007) Identi fi cation of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc Natl Acad Sci USA 104:18439-18444 (Pubitemid 350210715)
54. Hsiao SH, Huang TH et al (2009) Excavating relics of DNA methylation changes during the development of neoplasia. Semin Cancer Biol 19:198-208
55. Hsiao SH, Lee KD et al (2010) DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination. Biochem Biophys Res Commun 400:305-312
56. Hsu CC, Li HP et al (2010) Targeted methylation of CMV and E1A viral promoters. Biochem Biophys Res Commun 402:228-234
57. Hsu CC, Leu YW et al (2011) Functional characterization of Trip10 in cancer cell growth and survival. J Biomed Sci 18:12
58. Ji H, Ehrlich LI et al (2010) Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 467:338-342
59. Jones PA, Martienssen R (2005) A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res 65:11241-11246 (Pubitemid 41821675)
60. Jones PA, Taylor SM et al (1983) Inhibition of DNA methylation by 5-azacytidine. Recent Results Cancer Res 84:202-211
61. Jung JW, Lee S et al (2010) Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3. Cell Mol Life Sci 67:1165-1176
62. Kalari S, Pfeifer GP (2010) Identi fi cation of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet 70:277-308
63. Kang TH, Lee JH et al (2007) Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res 67:802-811
64. Kierszenbaum AL (2002) Genomic imprinting and epigenetic reprogramming: unearthing the garden of forking paths. Mol Reprod Dev 63:269-272
65. Kim D, Yang JY et al (2009) Overexpression of alpha-catenin increases osteoblastic differentiation in mouse mesenchymal C3H10T1/2 cells. Biochem Biophys Res Commun 382:745-750
66. Kirmizis A, Bartley SM et al (2004) Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev 18:1592-1605 (Pubitemid 38868910)
67. Klopp AH, Gupta A et al (2011) Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29:11-19
68. Krause DS, Theise ND et al (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105:369-377 (Pubitemid 32455343)
69. Lakshmipathy U, Hart RP (2008) Concise review: microRNA expression in multipotent mesenchymal stromal cells. Stem Cells 26:356-363 (Pubitemid 351413595)
70. Lan F, Bayliss PE et al (2007) A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449:689-694 (Pubitemid 47552096)
71. Lau PN, Cheung P (2011) Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing. Proc Natl Acad Sci USA 108:2801-2806
72. Lee KD, Kuo TK et al (2004) In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40:1275-1284 (Pubitemid 39657001)
73. Lee OK, Kuo TK et al (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669-1675 (Pubitemid 38268958)
74. Leu YW, Rahmatpanah F et al (2003) Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res 63:6110-6115 (Pubitemid 37255146)
75. Leu YW, Yan PS et al (2004) Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res 64:8184-8192 (Pubitemid 39491754)
76. Li E (2002) Chromatin modi fi cation and epigenetic reprogramming in mammalian development. Nat Rev Genet 3:662-673 (Pubitemid 34984255)
77. Lin Y, Weisdorf DJ et al (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71-77 (Pubitemid 30036389)
78. Lin YS, Shaw AY et al (2011) Identi fi cation of novel DNA methylation inhibitors via a twocomponent reporter gene system. J Biomed Sci 18:3
79. Liu YZ, Shao Z et al (2010) Prediction of Polycomb target genes in mouse embryonic stem cells. Genomics 96:17-26
80. Locke M, Feisst V et al (2011) Concise review: human adipose-derived stem cells (ASC): separating promise from clinical need. Stem Cells 29:404-411
81. Lodhi IJ, Chiang SH et al (2007) Gapex-5, a Rab31 guanine nucleotide exchange factor that regulates Glut4 trafficking in adipocytes. Cell Metab 5:59-72 (Pubitemid 44933113)
82. Lopez MJ, Spencer ND (2011) In vitro adult rat adipose tissue-derived stromal cell isolation and differentiation. Methods Mol Biol 702:37-46
83. Martin DI, Cropley JE et al (2008) Environmental influence on epigenetic inheritance at the Avy allele. Nutr Rev 66:S12-S14
84. Mathieu O, Probst AV et al (2005) Distinct regulation of histone H3 methylation at lysines 27 and 9 by CpG methylation in Arabidopsis. EMBO J 24:2783-2791 (Pubitemid 41170027)
85. Messmer S, Franke A et al (1992) Analysis of the functional role of the Polycomb chromo domain in Drosophila melanogaster. Genes Dev 6:1241-1254
86. Miller SA, Mohn SE et al (2010) Jmjd3 and UTX play a demethylase- independent role in chromatin remodeling to regulate T-box family member-dependent gene expression. Mol Cell 40:594-605
87. Mohn F, Weber M et al (2008) Lineage-speci fi c polycomb targets and de novo DNA methylation de fi ne restriction and potential of neuronal progenitors. Mol Cell 30:755-766
88. Momin EN, Vela G et al (2010) The oncogenic potential of mesenchymal stem cells in the treatment of cancer: directions for future research. Curr Immunol Rev 6:137-148
89. Morgan HD, Sutherland HG et al (1999) Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 23:314-318 (Pubitemid 29526429)
90. Noer A, Boquest AC et al (2007) Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence. BMC Cell Biol 8:18
91. Noer A, Lindeman LC et al (2009) Histone H3 modi fi cations associated with differentiation and long-term culture of mesenchymal adipose stem cells. Stem Cells Dev 18:725-736
92. Okitsu CY, Hsieh JC et al (2010) Transcriptional activity affects the H3K4me3 level and distribution in the coding region. Mol Cell Biol 30:2933-2946
93. Opavsky R, Wang SH et al (2007) CpG island methylation in a mouse model of lymphoma is driven by the genetic con fi guration of tumor cells. PLoS Genet 3:1757-1769 (Pubitemid 47510267)
94. Pacini S, Carnicelli V et al (2010) Constitutive expression of pluripotency-associated genes in mesodermal progenitor cells (MPCs). PLoS One 5:e9861
95. Papp B, Muller J (2006) Histone trimethylation and the maintenance of transcriptional ON and OFF states by trxG and PcG proteins. Genes Dev 20:2041-2054 (Pubitemid 44157456)
96. Pasini D, Malatesta M et al (2010) Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res 38:4958-4969
97. Petersen BE, Bowen WC et al (1999) Bone marrow as a potential source of hepatic oval cells. Science 284:1168-1170 (Pubitemid 29288406)
98. Pittenger MF, Mackay AM et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147 (Pubitemid 29282067)
99. Pontikoglou C, Deschaseaux F et al (2011) Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev 7:569-589
100. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74 (Pubitemid 27161245)
101. Rajasekhar VK, Begemann M (2007) Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective. Stem Cells 25:2498-2510 (Pubitemid 47582742)
102. Reik W (2007) Stability and fl exibility of epigenetic gene regulation in mammalian development. Nature 447:425-432 (Pubitemid 46816749)
103. Robert MF, Morin S et al (2003) DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33:61-65 (Pubitemid 36068683)
104. Ross SA (2003) Diet and DNA methylation interactions in cancer prevention. Ann N Y Acad Sci 983:197-207 (Pubitemid 36399332)
105. Salem HK, Thiemermann C (2010) Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28:585-596
106. Sanchez-Ramos J, Song S et al (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164:247-256 (Pubitemid 32008970)
107. Sasaki H, Matsui Y (2008) Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat Rev Genet 9:129-140
108. Sawarkar R, Paro R (2010) Interpretation of developmental signaling at chromatin: the Polycomb perspective. Dev Cell 19:651-661
109. Schlesinger Y, Straussman R et al (2007) Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39:232-236 (Pubitemid 46184355)
110. Schubeler D (2009) Epigenomics: methylation matters. Nature 462:296-297
111. Schwartz YB, Kahn TG et al (2010) Alternative epigenetic chromatin states of polycomb target genes. PLoS Genet 6:e1000805
112. Seki Y, Yamaji M et al (2007) Cellular dynamics associated with the genome-wide epigenetic reprogramming in migrating primordial germ cells in mice. Development 134:2627-2638 (Pubitemid 47225959)
113. Sethe S, Scutt A et al (2006) Aging of mesenchymal stem cells. Ageing Res Rev 5:91-116 (Pubitemid 43139669)
114. Shafa M, Krawetz R et al (2010) Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure. Bioessays 32:791-799
115. Sibani S, Melnyk S et al (2002) Studies of methionine cycle intermediates (SAM, SAH), DNA methylation and the impact of folate deficiency on tumor numbers in Min mice. Carcinogenesis 23:61-65 (Pubitemid 34213552)
116. Siddiqi S, Mills J et al (2010) Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas. Curr Stem Cell Res Ther 5:63-73
117. Simile MM, Pascale R et al (1994) Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. Cancer Lett 79:9-16 (Pubitemid 24146715)
118. Simon JA, Kingston RE (2009) Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 10:697-708
119. Sparmann A, van Lohuizen M (2006) Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6:846-856 (Pubitemid 44629896)
120. Spencer ND, Lopez MJ (2011) In vitro adult canine adipose tissue-derived stromal cell growth characteristics. Methods Mol Biol 702:47-60
121. Spivakov M, Fisher AG (2007) Epigenetic signatures of stem-cell identity. Nat Rev Genet 8:263-271 (Pubitemid 46439288)
122. Su Y, Deng B et al (2011) Polycomb group genes in stem cell self-renewal: a double-edged sword. Epigenetics 6:16-19
123. Surani MA, Hayashi K et al (2007) Genetic and epigenetic regulators of pluripotency. Cell 128:747-762 (Pubitemid 46273582)
124. Tate PH, Bird AP (1993) Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev 3:226-231 (Pubitemid 23108662)
125. Teng IW, Hou PC et al (2011) Targeted methylation of two tumor suppressor genes is suf fi cient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res 71:4653-4663
126. Theise ND, Badve S et al (2000) Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31:235-240 (Pubitemid 30033713)
127. Theise ND, Nimmakayalu M et al (2000) Liver from bone marrow in humans. Hepatology 32:11-16 (Pubitemid 30432360)
128. Tiwari VK, McGarvey KM et al (2008) PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biol 6:2911-2927
129. Trento C, Dazzi F (2010) Mesenchymal stem cells and innate tolerance: biology and clinical applications. Swiss Med Wkly 140:w13121
130. Turek-Plewa J, Jagodzinski PP (2005) The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 10:631-647 (Pubitemid 43161688)
131. Vincent A, Van Seuningen I (2009) Epigenetics, stem cells and epithelial cell fate. Differentiation 78:99-107
132. Wei Y, Xia W et al (2008) Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 47:701-706
133. Wei G, Wei L et al (2009) Global mapping of H3K4me3 and H3K27me3 reveals speci fi city and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30:155-167
134. Weinhofer I, Hehenberger E et al (2010) H3K27me3 pro fi ling of the endosperm implies exclusion of polycomb group protein targeting by DNA methylation. PLoS Genet 6:e1001152
135. Wolff GL, Kodell RL et al (1998) Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 12:949-957 (Pubitemid 28359576)
136. Wu SC, Zhang Y (2010) Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 11:607-620
137. Yamada Y, Watanabe A (2010) Epigenetic codes in stem cells and cancer stem cells. Adv Genet 70:177-199
138. Yamasaki-Ishizaki Y, Kayashima T et al (2007) Role of DNA methylation and histone H3 lysine 27 methylation in tissue-speci fi c imprinting of mouse Grb10. Mol Cell Biol 27:732-742 (Pubitemid 46080138)
139. Yang XF (2007) Immunology of stem cells and cancer stem cells. Cell Mol Immunol 4:161-171
140. Yuan R, Fan S et al (2001) Altered gene expression pattern in cultured human breast cancer cells treated with hepatocyte growth factor/scatter factor in the setting of DNA damage. Cancer Res 61:8022-8031 (Pubitemid 33049396)
141. Zager RA, Johnson AC (2010) Progressive histone alterations and proin fl ammatory gene activation: consequences of heme protein/iron-mediated proximal tubule injury. Am J Physiol Renal Physiol 298:F827-F837
142. Zeng X (2007) Human embryonic stem cells: mechanisms to escape replicative senescence? Stem Cell Rev 3:270-279 (Pubitemid 351526204)
143. Zheng C, Yang S et al (2009) Human multipotent mesenchymal stromal cells from fetal lung expressing pluripotent markers and differentiating into cell types of three germ layers. Cell Transplant 18:1093-1109
144. Jackson KA, Majka SM et al (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. JCI 107:1395-1402 (Pubitemid 32522033)